Hajjar, Braa
Zuo, Jieyu
Park, Chulhun
Azarmi, Shirzad
Silva, Daniela Amaral
Bou-Chacra, Nádia Araci
Löbenberg, Raimar http://orcid.org/0000-0002-0919-0213
Article History
Received: 29 December 2021
Accepted: 20 March 2022
First Online: 4 April 2022
Declarations
: The authors declare that this article does not contain any studies with human and animal subjects performed by any of the authors. Dr. Azarmi and Dr. Löbenberg are co-founders of RS Therapeutics Inc.